000			02234 a2200625 4500
005			20250515154517.0
264		0	_c20090716
008			200907s 0 0 eng d
022			_a1351-0088
024	7		_a10.1677/ERC-08-0130 _2doi
040			_aNLM _beng _cNLM
100	1		_aFestuccia, Claudio
245	0	0	_aAzacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models. _h[electronic resource]
260			_bEndocrine-related cancer _cJun 2009
300			_a401-13 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aAzacitidine _xtherapeutic use
650	0	4	_aBlotting, Western
650	0	4	_aCaspase 3 _xmetabolism
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aCyclin D1 _xmetabolism
650	0	4	_aCyclin-Dependent Kinase Inhibitor p16 _xmetabolism
650	0	4	_aCyclin-Dependent Kinase Inhibitor p21 _xmetabolism
650	0	4	_aCyclin-Dependent Kinase Inhibitor p27 _xmetabolism
650	0	4	_aDisease Models, Animal
650	0	4	_aDocetaxel
650	0	4	_aDrug Synergism
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFlow Cytometry
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aProstatic Neoplasms _xdrug therapy
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xmetabolism
650	0	4	_aSignal Transduction
650	0	4	_aTaxoids _xadministration & dosage
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_abcl-2 Homologous Antagonist-Killer Protein _xmetabolism
650	0	4	_abcl-2-Associated X Protein _xmetabolism
700	1		_aGravina, Giovanni Luca
700	1		_aD'Alessandro, Anna Maria
700	1		_aMuzi, Paola
700	1		_aMillimaggi, Danilo
700	1		_aDolo, Vincenza
700	1		_aRicevuto, Enrico
700	1		_aVicentini, Carlo
700	1		_aBologna, Mauro
773	0		_tEndocrine-related cancer _gvol. 16 _gno. 2 _gp. 401-13
856	4	0	_uhttps://doi.org/10.1677/ERC-08-0130 _zAvailable from publisher's website
999			_c18600526 _d18600526